Trademark: 76345887
Word
SERENEX
Status Date
Friday, March 4, 2011
Registration Number
2870061
Registration Date
Tuesday, August 3, 2004
Filing Date
Thursday, December 6, 2001
Published for Opposition
Tuesday, July 16, 2002
Cancellation Date
Friday, March 4, 2011
42 Drug discovery services; pharmaceutical research services; pre-clinical screening, and clinical research and evaluation services; proteomics and pharmacology research services; development of human disease models for use in evaluation of drugs and discovery of new drugs; drug discovery, drug screening, pre-clinical, and pharmaceutical programs; compilation of databases for use in pharmaceutical research; consultancy, information and advisory services for to all the aforesaid services, all of the foregoing services provided exclusively to researchers engaged in drug discovery and drug development
Mar 4, 2011
Cancelled Sec. 8 (6-Yr)
Aug 6, 2007
Assignment Of Ownership Not Updated Automatically
Aug 3, 2004
Registered-Principal Register
May 7, 2004
Allowed Principal Register - Sou Accepted
May 6, 2004
Examiners Amendment Mailed
Mar 29, 2004
Non-Final Action Mailed
Mar 24, 2004
Assigned To Examiner
Mar 23, 2004
Case File In Ticrs
Mar 15, 2004
Statement Of Use Processing Complete
Feb 26, 2004
Use Amendment Filed
Feb 26, 2004
Paper Received
Sep 16, 2003
Noa Mailed - Sou Required From Applicant
Jul 8, 2003
Opposition Terminated No. 999999
Jul 8, 2003
Opposition Dismissed No. 999999
Jan 14, 2003
Opposition Instituted No. 999999
Aug 13, 2002
Extension Of Time To Oppose Received
Jul 16, 2002
Published For Opposition
Jun 26, 2002
Notice Of Publication
Apr 16, 2002
Approved For Pub - Principal Register
Apr 11, 2002
Examiner's Amendment Mailed
Apr 10, 2002
Previous Allowance Count Withdrawn
Apr 10, 2002
Approved For Pub - Principal Register
Mar 22, 2002
Assigned To Examiner
Trademark Alertz updated from USPTO on 2030-01-24
